Canexis Pharma AG is building its new company building southwest of Schlattingen as a two-story attic building with a total volume of 6500 cubic meters. The building is scheduled to be completed by fall 2022; The aim is for the first deliveries after acceptance in 2023.
In the next few years we would like to develop into the leading company in Europe. The biomass required comes from Switzerland and other European countries such as Italy or Spain. Canexis products are extracts, distillates and isolates of the cannabis plant. Clean rooms and several pharmaceutical processing plants are being built in Schlattingen in order to be able to supply pharmacies and pharmaceutical wholesalers across Europe in the future. In addition to the medical market, Canexis will serve the cosmetic market and, if possible, also the food market.
The experienced company IE Life Science was chosen as the implementation partner and general contractor. You can find more information in the Newspaper article.